首页> 美国卫生研究院文献>Health and Quality of Life Outcomes >Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: Results from a randomized controlled Phase III study

【2h】

Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: Results from a randomized controlled Phase III study

机译：与美国一般人群规范相比阿达木单抗可改善中度至重度斑块状牛皮癣患者的健康相关生活质量：一项随机对照III期研究的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

ObjectiveTo evaluate the impact of adalimumab on health-related quality of life (HRQOL) for patients with moderate to severe plaque psoriasis.

机译：目的评估阿达木单抗对中度至重度斑块状牛皮癣患者健康相关生活质量（HRQOL）的影响。

著录项

期刊名称 Health and Quality of Life Outcomes
作者
Dennis A Revicki; Alan Menter; Steven Feldman; Miriam Kimel; Neesha Harnam; Mary K Willian;
展开▼
作者单位

展开▼
年(卷),期 2008(6),-1
年度 2008
页码 75
总页数 8
原文格式 PDF
正文语种
中图分类医院、综合医院;中医院;
关键词

相似文献

外文文献
中文文献
专利

1. Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis. [J] . Revicki D, Willian MK, Saurat JH, British Journal of Dermatology . 2008,第3期

机译：阿达木单抗治疗对健康相关的生活质量和其他患者报告的结局的影响：一项针对中度至重度斑块状牛皮癣患者的16周随机对照试验的结果。
2. Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis [J] . Feldman Steven R., Thaci Diamant, Gooderham Melinda, Journal of the American Academy of Dermatology . 2016,第6期

机译：Tofacitinib改善瘙痒和与健康相关的生活质量长达52周：中度至重度斑块状牛皮癣患者的两项随机III期试验结果
3. y Clinical similarity of the biosimilar ABP 501 compared with adalimumab after single transition: long-term results from a randomized controlled, double-blind, 52-week, phase III trial in patients with moderate-to-severe plaque psoriasis [J] . Papp K., Bachelez H., Costanzo A., British Journal of Dermatology . 2017,第6期

机译：双转型后，生物杀菌剂ABP 501的临床相似性：随机控制，双盲，52周，中度至重度斑块牛皮癣患者的长期结果
4. A randomized controlled study of emotion and quality of life on mild to moderate insomnia intervened by Chinese Medicine in integrated program [C] . Li Yan, Xu Biyun, Liu Peng, 2012 IEEE International Conference on Bioinformatics and Biomedicine Workshops. . 2012

机译：中医干预综合治疗中轻度失眠情绪与生活质量的随机对照研究
5. The impact of pruritus on the health-related quality of life of patients with chronic plaque psoriasis [D] . Majeski, Candace Julie Ann 2006

机译：瘙痒对慢性斑块牛皮癣患者健康有关质量的影响
6. Efficacy and safety of adalimumab in Chinese patients with moderate‐to‐severe plaque psoriasis: results from a phase 3 randomized placebo‐controlled double‐blind study [O] . L. Cai, J. Gu, J. Zheng, -1

机译：阿达木单抗在中国中度至重度斑块状牛皮癣患者中的疗效和安全性：一项来自3期随机安慰剂对照双盲研究的结果
7. Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: Results from a randomized, controlled Phase III study [O] . Dennis A Revicki, Alan Menter, Steven Feldman, 2008

机译：与美国一般人群规范相比，阿达木单抗可改善中度至重度斑块状牛皮癣患者的健康相关生活质量：一项随机对照III期研究的结果

Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: Results from a randomized controlled Phase III study

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅